Searched for
BIOPHARMACEUTICAL COMPANY
GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...- “Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...
- Bayer to buy Perfuse Therapeutics in up to $2.45 billion dealBayer is set to acquire Perfuse Therapeutics in a deal valued up to $2.45 billion. This strategic move aims to enhance Bayer's eye care tre...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- All our AI models have scientists in loop, says MSD chief AI officerMSD's Chief AI Officer, Anton Groom, highlights AI's transformative role in drug discovery. AI models like TEDDY and KERMT are assisting sc...
- Bengaluru horror: 35-year-old woman allegedly gang-raped by four, then fled away with refrigerator, washing machine and LED TVIn a shocking incident in southeast Bengaluru, a 35-year-old woman was gang-raped at her friend's house by four men. The perpetrators, afte...
- Biocon raises Rs 4,500 crore through successful QIPBiocon, a leading biopharmaceutical company, successfully raised Rs 4,500 crore through QIP. This marks their first equity funding since 20...
- MSD Pharma, Delhi Capitals partner to create awareness about cervical cancer preventionMSD Pharmaceuticals and Delhi Capitals have partnered to raise cervical cancer prevention awareness in India. The women's T20 team will dis...
- PlasmaGen Biosciences raises Rs 225 crore in equity fundingThe Bengaluru-based startup will use the proceeds to boost growth of plasma products. It is also expected to use the corpus to expand its p...
- Sun Pharma completes acquisition of Concert PharmaceuticalsThe drug major has successfully completed the acquisition of Concert Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company ...
- Bristol Myers Squibb to invest Rs 800 crore to set up facility in Hyderabad for drug development, ITThe company plans to begin operations in Hyderabad later in 2023, with the potential over the next few years to employ approximately 1,500 ...
- Devastated to lose my husband: Kiran Mazumdar-Shaw"I am devastated to lose my husband, my mentor and soul mate. I will always be spiritually guided by John as I pursue my purpose. Rest in P...
- CCI clears Phoenix Parentco's acquisition of Parexel International CorporationThe proposed transaction pertains to acquisition of 100 per cent of the equity shareholding of Parexel International, according to a notice...
- CSIR-IICT, Bengaluru pharma firm join hands to manufacture anti-COVID drug 2-DGThe CSIR-Indian Institute of Chemical Technology (IICT) here and Bengaluru-based Anthem Biosciences Pvt Ltd have entered into an agreement ...
- Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater ChinaAs per the agreement, Rhizen will receive an undisclosed upfront cash payment and is eligible to receive additional development and commerc...
- Gilead nears deal to buy Immunomedics for more than $20 billion: ReportA deal for Immunomedics, whose cancer therapy Trodelvy is FDA-approved as a third-line treatment for an aggressive type of breast cancer ca...
- Nestle to buy Aimmune, valuing allergy treatment maker at $2.6 billionThe offer values the California-based biopharmaceutical company at $2.6 billion, including the $473 million that Nestle had already investe...
- Kiran Mazumdar Shaw bats for easing regulations on biotechnology sector"The erstwhile UPA regime and the present Modi government have taken some good steps, but have not done enough to improve the economy," Sha...
- Pharmaceutical Export Promotion Council of India seeks clarity from US on new generic drug fee normsPharmexcil has sought clarity from the United States Food and Drug Administration (USFDA ) on the new generic drug user fee norms.
- Aurobindo Pharma signs supply pact with AstraZenecaAurobindo Pharma said it has entered into an agreement with AstraZeneca to supply solid dosage & sterile products to emerging markets.
Load More
